Actively Recruiting
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
Led by University of Rochester · Updated on 2026-05-04
430
Participants Needed
1
Research Sites
221 weeks
Total Duration
On this page
Sponsors
U
University of Rochester
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators propose a randomized controlled trial of Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) vs. enhanced care (EC). TEACH-ER includes: 1) brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided for home asthma medications; 2) virtual primary care follow-up within 1 week of discharge using in-home telemedicine (Zoom) when possible, featuring provider prompts for guideline-based preventive therapy and home delivery of prescribed medications with pictorial action plans; 3) two additional in-home virtual visits to reinforce teaching, review treatment plans, label medications, and support effective management practices. The investigators will enroll 430 children (ages 3-12 yrs) from the two dedicated pediatric EDs in our region, and follow all participants for a 12-month period. The investigators will call caregivers to complete blinded follow-up telephone surveys at 3, 6, 9, and 12 months after discharge. The investigators will assess the effectiveness of TEACH-ER in reducing the need for additional asthma-related ED visits or hospitalizations in the 1-months after enrollment. Additional outcomes of interest include asthma symptoms, medication adherence, absenteeism from work and school, quality of life, and the delivery of care consistent with national asthma care guidelines.
CONDITIONS
Official Title
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Physician diagnosis of asthma confirmed by medical records or caregiver report
- Currently visiting the emergency department for an acute asthma attack requiring rescue medication
- Persistent asthma or poor control needing daily controller medication as defined by NHLBI guidelines, including more than 2 days per week of symptoms or rescue medication use, more than 2 nights per month with symptoms (or 1-2 nights if aged 3-4), or at least 1 episode in the past year requiring systemic corticosteroids (6 months for ages 3-4)
- Child is between 3 and 12 years old
- Child and caregiver live in the greater Rochester, NY metropolitan area (Monroe, Wayne, Ontario, Livingston, Genesee, and Orleans Counties)
- Emergency severity index triage scores between 2 and 5 (1 indicates highest severity)
You will not qualify if you...
- Unable to speak or understand English (low literacy is allowed)
- No access to a working phone for follow-up surveys
- Other significant medical conditions like cystic fibrosis, congenital heart disease, or other chronic lung diseases that affect asthma assessment
- Child is in foster care or legal guardian consent cannot be obtained
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Rochester Medical Center
Rochester, New York, United States, 14642
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here